Simplex Trading, LLC Ptc Therapeutics, Inc. Transaction History

Simplex Trading, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 04, 2023	BUY	$40.4 - $59.1 $97,081 - $142,017	2,403 New	2,403 $97,000
Q2 2022 Aug 03, 2022	BUY	$25.6 - $45.23 $183,014 - $323,349	7,149 Added 559.39%	8,427 $337,000
Q3 2021 Oct 28, 2021	SELL	$37.01 - $44.74 $7,402 - $8,948	-200 Reduced 13.53%	1,278 $55,000
Q2 2021 Aug 12, 2021	BUY	$37.95 - $49.37 $56,090 - $72,968	1,478 New	1,478 $62,000
Q2 2020 Jul 13, 2020	SELL	$42.56 - $54.98 $375,208 - $484,703	-8,816 Closed	0 $0
Q1 2020 Apr 29, 2020	BUY	$32.37 - $59.36 $285,373 - $523,317	8,816 New	8,816 $393,000
Q4 2018 Jan 16, 2019	SELL	$29.83 - $46.51 $712,787 - $1.11 Million	-23,895 Closed	0 $0
Q3 2018 Oct 23, 2018	BUY	$33.9 - $47.77 $668,982 - $942,693	19,734 Added 474.26%	23,895 $1.12 Million
Q2 2018 Jul 30, 2018	BUY	$25.7 - $47.88 $106,937 - $199,228	4,161 New	4,161 $140,000
Q1 2018 Apr 26, 2018	SELL	$17.46 - $32.59 $215,631 - $402,486	-12,350 Closed	0 $0
Q4 2017 Jan 10, 2018	SELL	$15.14 - $20.89 $328,538 - $453,313	-21,700 Reduced 63.73%	12,350 $205,000
Q3 2017 Oct 25, 2017	BUY	$16.81 - $21.61 $572,380 - $735,820	34,050	34,050 $681,000

221

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.27B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.